Mariné Leopoldo, Mertens Renato, Krämer Sch Albrecht, Valdés Francisco, Bergoeing Michel, Arriagada Ivette, Vergara Jeanette, Carvajal Claudia
Sección de Cirugía Vascular y Endovascular, División de Cirugía, Pontificia Universidad Católica de Chile, Chile.
Rev Med Chil. 2008 Dec;136(12):1535-41. Epub 2009 Mar 23.
Inferior vena cava (IVC) filters are used to prevent massive pulmonary embolism in cases where anticoagulation is contraindicated or has failed. It is usually implanted below the renal veins. In a few cases it is necessary to deploy the filter above them, with theoretical risk of secondary renal failure.
To report the experience with filters located above the renal veins.
Medical records of all patients with percutaneous suprarenal filters are reviewed.
Between May 1993 and May 2007, 361 percutaneous IVC filter procedures were performed. In thirty patients aged 19 to 77 years (average 48 years, 50% males), they were placed in suprarenal position (8,3%). Suprarenal IVC filters were implanted in patients with extensive caval thrombosis, renal vein thrombosis extending to cava, displacement of previous IVC filters and double IVC system. Jugular vein approach was the access of choice. Technical success was 100%, no death or pulmonary embolism occurred. Patients were followed from 1 to 165 months (average 57 months). Eight deaths were recorded, five in patients with cancer No patient had renal failure on follow up (average creatinine 0.90+0,26 mg/dL). Three patients developed a new deep vein thrombosis (10%), without pulmonary embolism.
In this retrospective analysis of patients, suprarenal placement of IVC filters was not associated to secondary renal failure, and showed good short and long term results.
下腔静脉(IVC)滤器用于在抗凝治疗禁忌或失败的情况下预防大面积肺栓塞。它通常植入肾静脉下方。在少数情况下,有必要将滤器部署在肾静脉上方,理论上存在继发肾衰竭的风险。
报告肾静脉上方放置滤器的经验。
回顾了所有经皮肾上放置滤器患者的病历。
在1993年5月至2007年5月期间,共进行了361例经皮IVC滤器置入手术。在30例年龄19至77岁(平均48岁,50%为男性)的患者中,滤器被放置在肾上位置(8.3%)。肾上IVC滤器植入用于广泛腔静脉血栓形成、肾静脉血栓延伸至腔静脉、先前IVC滤器移位以及双IVC系统的患者。颈静脉途径是首选的入路。技术成功率为100%,未发生死亡或肺栓塞。对患者进行了1至165个月(平均57个月)的随访。记录到8例死亡,其中5例为癌症患者。随访期间无患者发生肾衰竭(平均肌酐0.90 + 0.26mg/dL)。3例患者出现新的深静脉血栓形成(10%),无肺栓塞。
在对这些患者的回顾性分析中,IVC滤器的肾上放置与继发肾衰竭无关,且显示出良好的短期和长期结果。